CHICOPEE, Mass. (WWLP) – World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease. The American Lung Association states that lung ...

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

University of Queensland researcher Arutha Kulasinghe studied lung biopsies from the tumours of almost 250 patients with ...

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection through screening, combined with advancements in treatment, significantly ...

Tobacco remains the leading preventable cause of cancer death in the U.S., despite a dramatic decline in smoking, a new ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

Two companion studies published in Cancer Research by scientists at Moffitt Cancer Center identify distinct but complementary ...

Aug. 6, 2005 — -- In her West Bloomfield, Mich., home, Lisa Roffman wiped away tears as she read from a journal she keeps for her 9-year-old daughter, Leah. "You are a special gift to the world," ...

A new targeted therapy is significantly improving lung cancer patient outcomes. The drug is called Osimertinib, or brand name Tagrisso. It’s given after a combination of chemotherapy and radiation ...

Lung cancer symptoms may appear differently in women than in men. Lung cancer tends to be diagnosed at a later stage in females, when the disease has already advanced. This means women may be more ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting immune checkpoint inhibitors is associated with increased overall ...